pISSN 1226-6051
eISSN 2508-786X
eISSN 2508-786X
Concomitant use of nephrotoxic drugs
| Nephrotoxic drugs, n (%) | Tacrolimus group (n=61) | Basiliximab group (n=24) | |
|---|---|---|---|
| Acyclovir | 3 (4.9) | 0 (0.0) | 0.555 |
| Amikacin | 7 (11.5) | 12 (50.0) | <0.001 |
| Liposomal amphotericin B | 5 (8.2) | 3 (12.5) | 0.682 |
| Amphotericin B | 4 (6.6) | 2 (8.3) | 1.000 |
| Ceftazidime | 5 (8.2) | 8 (33.3) | 0.007 |
| Celecoxib | 1 (1.6) | 0 (0.0) | 1.000 |
| Colistin | 22 (36.1) | 17 (70.8) | 0.004 |
| Furosemide | 50 (82.0) | 22 (91.7) | 0.334 |
| Ganciclovir | 47 (77.0) | 24 (100.0) | 0.008 |
| Ibuprofen | 15 (24.6) | 3 (12.5) | 0.219 |
| Iodixanol | 9 (14.8) | 5 (20.8) | 0.525 |
| Iohexol | 16 (26.2) | 11 (45.8) | 0.081 |
| Ketorolac | 1 (1.6) | 0 (0.0) | 1.000 |
| Metformin | 18 (29.5) | 2 (8.3) | 0.038 |
| Naproxen | 1 (1.6) | 0 (0.0) | 1.000 |
| Piperacillin/tazobactam | 14 (23.0) | 8 (33.3) | 0.325 |
| Tobramycin | 0 (0.0) | 1 (4.2) | 0.282 |
| Topiramate | 1 (1.6) | 1 (4.2) | 0.487 |
| Valganciclovir | 57 (93.4) | 16 (66.7) | 0.003 |
| Vancomycin | 12 (19.7) | 14 (58.3) | <0.001 |
† Pearson’s chi-square test
‡ Fisher’s exact test